C.M. Bidwell & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-201
| Closed | -$119K | – | 530 |
|
|
2022
Q2 | $119K | Hold |
201
| – | – | 0.09% | 195 |
|
|
2022
Q1 | $140K | Sell |
201
-252
| -56% | -$176K | 0.09% | 201 |
|
|
2021
Q4 | $286K | Buy |
453
+252
| +125% | +$159K | 0.18% | 102 |
|
|
2021
Q3 | $122K | Buy |
+201
| New | +$122K | 0.08% | 229 |
|
|
2021
Q1 | – | Sell |
-156
| Closed | -$75K | – | 544 |
|
|
2020
Q4 | $75K | Sell |
156
-359
| -70% | -$173K | 0.06% | 256 |
|
|
2020
Q3 | $288K | Sell |
515
-155
| -23% | -$86.7K | 0.27% | 66 |
|
|
2020
Q2 | $418K | Buy |
670
+461
| +221% | +$288K | 0.38% | 46 |
|
|
2020
Q1 | $102K | Buy |
+209
| New | +$102K | 0.11% | 168 |
|
|
2019
Q2 | – | Sell |
-520
| Closed | -$214K | – | 445 |
|
|
2019
Q1 | $214K | Sell |
520
-15
| -3% | -$6.17K | 0.21% | 123 |
|
|
2018
Q4 | $200K | Buy |
+535
| New | +$200K | 0.22% | 126 |
|
|
2018
Q2 | – | Sell |
-1,050
| Closed | -$362K | – | 444 |
|
|
2018
Q1 | $362K | Buy |
1,050
+50
| +5% | +$17.2K | 0.33% | 83 |
|
|
2017
Q4 | $376K | Buy |
+1,000
| New | +$376K | 0.32% | 92 |
|
|
2016
Q4 | – | Sell |
-10,020
| Closed | -$4.03M | – | 295 |
|
|
2016
Q3 | $4.03M | Hold |
10,020
| – | – | 0.96% | 39 |
|
|
2016
Q2 | $3.5M | Hold |
10,020
| – | – | 0.87% | 70 |
|
|
2016
Q1 | $3.61M | Buy |
+10,020
| New | +$3.61M | 0.9% | 62 |
|